N.J. called hot spot for Candida auris

The CDC says most cases of Candida auris in the United States are in New York City, Chicago and New Jersey


The Centers for Disease Control and Prevention (CDC) saya New Jersey is one of the hot spots for Candida auris, according to an article on the CBS Philly website.

The CDC says most of Candida auris in the United States are in New York City, Chicago and New Jersey, where there are 124 confirmed cases along with 22 probable cases.

There have been 715 confirmed or suspected cases of the rare fungus in the United States.

Experts say hospital infection control is a critical part of preventing the infection.

Read the article.



August 12, 2019


Topic Area: Infection Control


Recent Posts

Preparing Healthcare Facilities for Severe Thunderstorms

Hardening plans and collaboration with local stakeholders can aid in prep for severe weather.


University of South Carolina Opens New Brain Health Center

The center is aimed at expanding access to specialized care for patients with cognitive conditions.


NLCS Strengthens Safety and Compliance with Comprehensive Electrical Program

Case study: A renewed partnership with Siemens helps the senior living provider meet NFPA 70B standards, reduce risk, and enhance reliability across its communities.


Infrastructure Issues: Assisting Mobility-Challenged Visitors

Parking constraints, mobility needs and patient experience priorities are elevating arrival pathways as a strategic planning issue.


Willis-Knighton Medical Center Upgrades Chilled Water Plant

The medical center sought upgrades through Trane to add capacity, control comfort, increase redundancy and reduce energy costs.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.